Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck

Burkitt Lymphoma

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Thyroid Neoplasms

Rhabdomyosarcoma, Embryonal

Medulloblastoma

Pelvic Neoplasms

Breast Neoplasms

Esophageal Neoplasms

Diffuse Intrinsic Pontine Glioma

Oligodendroglioma

Pancreatic Neoplasms

Oligodendroglioma

Esophageal Neoplasms

Prostatic Neoplasms

Brain Neoplasms

Nasopharyngeal Carcinoma, Pathologic Complete Response

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

Nasopharyngeal Carcinoma

Anus Neoplasms

Carcinoma, Hepatocellular

Breast Neoplasms

Prostatic Neoplasms

Locally Advanced Rectal Cancer (LARC)

Radiation Injuries, Disease Progression

Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)

Genital Diseases, Male, Prostatic Diseases

Castration-resistant Prostate Cancer

Neoplasm Metastasis, Prostatic Neoplasms

Uterine Cervical Neoplasms

Oropharyngeal Neoplasms

Nasopharyngeal Carcinoma

Uterine Cervical Neoplasms

Breast Neoplasms

Stomach Neoplasms

Rectal Neoplasms

Astrocytoma, Oligodendroglioma

Clinical Trials

STABLE-MATES

IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

HOPE

RePaIr-HN

Adjuvant Radiotherapy in High Risk Locally Advanced DTC

Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

BEFORE

OLIGAMI

CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC

BIOMEDE 2

ImproveCodel

LAP100

POLO

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancer, INNOVATE Trial

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy

FIL_GAZEBO

Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.

KANALRAD

Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC

PRATO

GrandP/SPCG19

Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study

Omitting CTV for Primary Tumor in LS-SCLC

PREDIR-NEOREC

Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)

MEDCARE

SPARKLE

Postoperative Adjuvant Chemotherapy for Thymic Cancer (FUSCC-Thymic 3)

ONCOCOL01

SwallPEG

Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant Chemotherpy

Adjuvant Concurrent Chemoradiotherapy Versus Radiotherapy in Early-stage Cervical Cancer Patients

Radiotherapy for Extracranial Oligometastatic Breast Cancer

Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ Adenocarcinoma

JCOG1801

Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma